Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Athira Pharma Inc (NQ: ATHA )

0.6416 -0.0285 (-4.25%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 18, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Athira Pharma Inc

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Athira Pharma, Inc. (ATHA) Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
ATHIRA SHAREHOLDER ALERT
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Initial Public Offering Intellectual Property Lawsuit
Exposures Financial Intellectual Property Legal
Keller Rohrback Files Suit Against Athira Pharma for Misrepresentations in IPO Registration Statement
From Keller Rohrback
Via Business Wire
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Athira Pharma, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Athira Pharma, Inc. (ATHA)
From Glancy Prongay & Murray LLP
Via Business Wire
ATHA INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Athira Pharma, Inc.
NEW YORK, NY / ACCESSWIRE / June 29, 2021 / Bernstein Liebhard, a nationally acclaimed investor rights law firm, announces that a securities class action lawsuit has been filed on behalf of investors... 
From Bernstein Liebhard LLP
Via AccessWire
Topics Intellectual Property Lawsuit
Exposures Financial Intellectual Property Legal
ATHIRA ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Athira Pharma, Inc. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Athira Pharma, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
ATHIRA DEADLINE ALERT
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Initial Public Offering Intellectual Property Lawsuit
Exposures Financial Intellectual Property Legal
EQUITY ALERT: Rosen Law Firm Encourages Athira Pharma, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline – ATHA
From Rosen Law Firm
Via Business Wire
Notice of Lead Plaintiff Deadline for Shareholders in the Athira Pharma, Inc. Class Action Lawsuit – ATHA
From Robbins Geller Rudman & Dowd LLP
Via Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Athira Pharma, Inc. (ATHA) Investors
From Law Offices of Howard G. Smith
Via Business Wire
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Athira Pharma, Inc. and Encourages Investors with Losses to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
ATHA CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit Against Athira Pharma, Inc.
From Glancy Prongay & Murray LLP
Via Business Wire
ONGOING INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Athira Pharma, Inc. and Encourages Investors with Losses to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
Alzheimer’s Treatment Market Is Anticipated To Reach $2 Billion By The End Of 2027
Via FinancialNewsMedia
Topics Death
Exposures Death
Glancy Prongay & Murray LLP, a National Class Action Law Firm, Continues Investigation of Athira Pharma, Inc. (ATHA) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
The Law Offices of Frank R. Cruz Continues Investigation of Athira Pharma, Inc. (ATHA) on Behalf of Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Athira Pharma, Inc. and Encourages Investors with Losses to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Athira Pharma, Inc. (ATHA) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Athira Pharma, Inc. and Encourages Investors with Losses to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
ATHIRA ALERT: Bragar Eagel & Squire, P.C. is Investigating Athira Pharma, Inc. on Behalf of Athira Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
Lost Money in Athira Pharma, Inc.?
From Gibbs Law Group
Via Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Athira Pharma, Inc. (ATHA) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of Athira Pharma, Inc. (ATHA) on Behalf of Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Athira Pharma, Inc. (ATHA) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
58 Biggest Movers From Friday
Gainers CAI International, Inc. (NYSE: CAI) shares surged 46.9% to close at $56.05 on Friday after the company agreed to a $1.1 billion takeover by Mitsubishi HC Capital Inc.... 
Via Benzinga
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Athira Pharma, Inc. and Encourages Investors with Losses to Contact the Firm
From The Schall Law Firm
Via Business Wire
Why Athira Pharma Crashed Today
There was a big shakeup in the biotech's C-suite. 
Via The Motley Fool
Mid-Afternoon Market Update: Dow Tumbles Over 400 Points; CAI International Shares Spike Higher
Toward the end of trading Friday, the Dow traded down 1.27% to 33,394.86 while the NASDAQ fell 0.92% to 14,031.05. The S&P also fell, dropping 1.03% to 4,178.31. The U.S. has... 
Via Benzinga
Topics Stocks
Exposures US Equities
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.